InMed Pharmaceuticals Inc. Common Shares (NASDAQ: INM) last traded at $1.46, down 7.59% on the session. The quote above updates while this page is open; the figures below are drawn from InMed Pharmaceuticals Inc. Common Shares’s own filings and are restated only when a new one is published.
InMed Pharmaceuticals Inc. Common Shares trades on NASDAQ under the ticker INM. Its market capitalisation is $4.84 million.
Valuation measures for InMed Pharmaceuticals Inc. Common Shares, derived from the latest quote and its most recent SEC filing.
| Market cap | $4.84M |
|---|---|
| Enterprise value | $1.92M |
| Price / sales | 1.07 |
| Price / book | 0.70 |
| Beta | 0.34 |
Trailing-twelve-month figures tagged in InMed Pharmaceuticals Inc. Common Shares's XBRL filings with the SEC.
| Revenue (TTM) | $4.51M |
|---|---|
| Net income (TTM) | -$8.51M |
| Gross margin | 29.73% |
| Return on equity | -123.48% |
| Cash | $5.16M |
Range and volume for INM over the past 52 weeks.
| 52-week high | $2.50 |
|---|---|
| 52-week low | $0.575 |
| Volume | 71.5K |
| Average volume | 948.1K |
| Previous close | $1.58 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.